Expansion of the neonatal platelet mass is achieved via an extension of platelet lifespan

Blood

Volumn 123, Issue 22, 2014, Pages 3381-3389

  Liu, Zhi Jian ^a   Hoffmeister, Karin M ^b   Hu, Zhongbo ^c   Mager, Donald E ^d   Ait Oudhia, Sihem ^d   Debrincat, Marlyse A ^e   Pleines, Irina ^e   Josefsson, Emma C ^e   Kile, Benjamin T ^e   Italiano Jr , Joseph ^a,b   Ramsey, Haley ^a   Grozovsky, Renata ^b   Veng Pedersen, Peter ^f   Chavda, Chaitanya ^a   Sola Visner, Martha ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c UNIVERSITY OF FLORIDA   (United States)

^d UNIVERSITY AT BUFFALO   (United States)

^e UNIVERSITY OF MELBOURNE   (Australia)

^f UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 [4 (4' CHLORO 2 BIPHENYLYLMETHYL) 1 PIPERAZINYL] N [4 [3 DIMETHYLAMINO 1 (PHENYLTHIOMETHYL)PROPYLAMINO] 3 NITROBENZENESULFONYL]BENZAMIDE; BH3 PROTEIN; PROTEIN BCL 2;

ADULT; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BIOTINYLATION; BLOOD VOLUME; BODY WEIGHT; CELL EXPANSION; CELL SURVIVAL; FLOW CYTOMETRY; HISTOLOGY; HUMAN; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MEGAKARYOPOIESIS; MOUSE; NEWBORN; NONHUMAN; PERINATAL DEVELOPMENT; PLATELET MASS; PRIORITY JOURNAL; PROTEIN ANALYSIS; THROMBOCYTE; THROMBOCYTE COUNT; THROMBOCYTE FUNCTION AND CHARACTERISTICS; THROMBOCYTE LIFESPAN; THROMBOCYTOPOIESIS;

ANIMALS; ANIMALS, NEWBORN; APOPTOSIS; BIPHENYL COMPOUNDS; BLOOD PLATELETS; CELL SURVIVAL; HUMANS; INFANT, NEWBORN; LIVER; MEAN PLATELET VOLUME; MEGAKARYOCYTES; MICE; NITROPHENOLS; PIPERAZINES; PLATELET COUNT; PROTO-ONCOGENE PROTEINS C-BCL-2; SPLEEN; SULFONAMIDES; THROMBOPOIESIS;

EID: 84901722801     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2013-06-508200     Document Type: Article

References (38)

1. Castle V, Andrew M, Kelton J, Giron D, Johnston M, Carter C. Frequency and mechanism of neonatal thrombocytopenia. J Pediatr. 1986; 108(5 Pt 1):749-755. (Pubitemid 16064127)
2. Mehta P, Vasa R, Neumann L, Karpatkin M. Thrombocytopenia in the high-risk infant. J Pediatr. 1980;97(5):791-794. (Pubitemid 11216851)
3. Christensen RD, Henry E, Wiedmeier SE, et al. Thrombocytopenia among extremely low birth weight neonates: data from a multihospital healthcare system. J Perinatol. 2006;26(6): 348-353. (Pubitemid 43811510)
4. Liu ZJ, Sola-Visner M. Neonatal and adult megakaryopoiesis. Curr Opin Hematol. 2011; 18(5):330-337.
5. Klusmann JH, Godinho FJ, Heitmann K, et al. Developmental stage-specific interplay of GATA1 and IGF signaling in fetal megakaryopoiesis and leukemogenesis. Genes Dev. 2010;24(15): 1659-1672.
6. Mazharian A, Watson SP, Severin S. Critical role for ERK1/2 in bone marrow and fetal liver-derived primary megakaryocyte differentiation, motility, and proplatelet formation. Exp Hematol. 2009; 37(10):1238-1249, e1235.
7. Bluteau O, Langlois T, Rivera-Munoz P, et al. Developmental changes in human megakaryopoiesis. J Thromb Haemost. 2013; 11(9):1730-1741.
8. Mason KD, Carpinelli MR, Fletcher JI, et al. Programmed anuclear cell death delimits platelet life span. Cell. 2007;128(6):1173-1186. (Pubitemid 46427871)
9. Zhang H, Nimmer PM, Tahir SK, et al. Bcl-2 family proteins are essential for platelet survival. Cell Death Differ. 2007;14(5):943-951. (Pubitemid 46655455)
10. Ren D, Tu HC, Kim H, et al. BID, BIM, and PUMA are essential for activation of the BAX-and BAK-dependent cell death program. Science. 2010;330(6009):1390-1393.
11. Willis SN, Fletcher JI, Kaufmann T, et al. Apoptosis initiated when BH3 ligands engage multiple Bcl-2 homologs, not Bax or Bak. Science. 2007;315(5813):856-859.
12. Kodama T, Takehara T, Hikita H, et al. BH3-only activator proteins Bid and Bim are dispensable for Bak/Bax-dependent thrombocyte apoptosis induced by Bcl-xL deficiency: molecular requisites for the mitochondrial pathway to apoptosis in platelets. J Biol Chem. 2011;286(16): 13905-13913.
13. Schoenwaelder SM, Jarman KE, Gardiner EE, et al. Bcl-xL-inhibitory BH3 mimetics can induce a transient thrombocytopathy that undermines the hemostatic function of platelets. Blood. 2011; 118(6):1663-1674.
14. Wilson WH, O'Connor OA, Czuczman MS, et al. Navitoclax, a targeted high-affinity inhibitor of BCL-2, in lymphoid malignancies: a phase 1 doseescalation study of safety, pharmacokinetics, pharmacodynamics, and antitumour activity. Lancet Oncol. 2010;11(12):1149-1159.
15. Josefsson EC, James C, Henley KJ, et al. Megakaryocytes possess a functional intrinsic apoptosis pathway that must be restrained to survive and produce platelets. J Exp Med. 2011; 208(10):2017-2031.
16. White MJ, Schoenwaelder SM, Josefsson EC, et al. Caspase-9 mediates the apoptotic death of megakaryocytes and platelets, but is dispensable for their generation and function. Blood. 2012; 119(18):4283-4290.
17. Hoffmeister KM, Felbinger TW, Falet H, et al. The clearance mechanism of chilled blood platelets. Cell. 2003;112(1):87-97. (Pubitemid 36106421)
18. Rumjantseva V, Grewal PK, Wandall HH, et al. Dual roles for hepatic lectin receptors in the clearance of chilled platelets. Nat Med. 2009; 15(11):1273-1280.
19. Kraemer BF, Weyrich AS, Lindemann S. Protein degradation systems in platelets. Thromb Haemost. 2013;110(5):920-924.
20. Nayak MK, Kulkarni PP, Dash D. Regulatory role of proteasome in determination of platelet life span. J Biol Chem. 2013;288(10):6826-6834.
21. Hu Z, Slayton WB, Rimsza LM, Bailey M, Sallmon H, Sola-Visner MC. Differences between newborn and adult mice in their response to immune thrombocytopenia. Neonatology. 2010;98(1): 100-108.
22. Liu ZJ, Italiano J Jr, Ferrer-Marin F, et al. Developmental differences in megakaryocytopoiesis are associated with up-regulated TPO signaling through mTOR and elevated GATA-1 levels in neonatal megakaryocytes. Blood. 2011;117(15): 4106-4117.
23. Alugupalli KR, Michelson AD, Barnard MR, Leong JM. Serial determinations of platelet counts in mice by flow cytometry. Thromb Haemost. 2001; 86(2):668-671. (Pubitemid 32743283)
24. Sands MS, Barker JE. Percutaneous intravenous injection in neonatal mice. Lab Anim Sci. 1999; 49(3):328-330. (Pubitemid 29284392)
25. Mock DM, Mock NI, Lankford GL, Burmeister LF, Strauss RG, Widness JA. Red cell volume can be accurately determined in sheep using a nonradioactive biotin label. Pediatr Res. 2008; 64(5):528-532.
26. Berger G, Hartwell DW, Wagner DD. P-Selectin and platelet clearance. Blood. 1998;92(11): 4446-4452. (Pubitemid 28544363)
27. Bertino AM, Qi XQ, Li J, Xia Y, Kuter DJ. Apoptotic markers are increased in platelets stored at 37 degrees C. Transfusion. 2003;43(7): 857-866. (Pubitemid 36753934)
28. Vogler M, Hamali HA, Sun XM, et al. BCL2/BCL-X (L) inhibition induces apoptosis, disrupts cellular calcium homeostasis, and prevents platelet activation. Blood. 2011;117(26):7145-7154.
29. Souers AJ, Leverson JD, Boghaert ER, et al. ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets. Nat Med. 2013;19(2):202-208.
30. Fuertes Marraco SA, Scott CL, Bouillet P, et al. Type I interferon drives dendritic cell apoptosis via multiple BH3-only proteins following activation by PolyIC in vivo. PLoS ONE. 2011;6(6):e20189.
31. Tada T, Widayati DT, Fukuta K. Morphological study of the transition of haematopoietic sites in the developing mouse during the peri-natal period. Anat Histol Embryol. 2006;35(4):235-240.
32. Wolber FM, Leonard E, Michael S, Orschell-Traycoff CM, Yoder MC, Srour EF. Roles of spleen and liver in development of the murine hematopoietic system. Exp Hematol. 2002;30(9): 1010-1019. (Pubitemid 35286617)
33. Slayton WB, Georgelas A, Pierce LJ, et al. The spleen is a major site of megakaryopoiesis following transplantation of murine hematopoietic stem cells. Blood. 2002;100(12):3975-3982. (Pubitemid 35396863)
34. Slayton WB, Wainman DA, Li XM, et al. Developmental differences in megakaryocyte maturation are determined by the microenvironment. Stem Cells. 2005;23(9): 1400-1408. (Pubitemid 41504927)
35. Calhoun DA, Li Y, Braylan RC, Christensen RD. Assessment of the contribution of the spleen to granulocytopoiesis and erythropoiesis of the midgestation human fetus. Early Hum Dev. 1996; 46(3):217-227. (Pubitemid 26370847)
36. Wiedmeier SE, Henry E, Sola-Visner MC, Christensen RD. Platelet reference ranges for neonates, defined using data from over 47,000 patients in a multihospital healthcare system. J Perinatol. 2009;29(2):130-136.
37. Mérino D, Khaw SL, Glaser SP, et al. Bcl-2, Bcl-x(L), and Bcl-w are not equivalent targets of ABT-737 and navitoclax (ABT-263) in lymphoid and leukemic cells. Blood. 2012;119(24): 5807-5816.
38. Kelly PN, White MJ, Goschnick MW, et al. Individual and overlapping roles of BH3-only proteins Bim and Bad in apoptosis of lymphocytes and platelets and in suppression of thymic lymphoma development. Cell Death Differ. 2010; 17(10):1655-1664.